Cameron Trenor

Cameron Trenor, MD, currently serves as Senior Vice President and Head of Translational Medicine at Cellarity, where efforts focus on translating innovative drug discovery to address unmet patient needs. Previously, Cameron held key roles at Boston Children's Hospital as a Pediatric Hematologist/Oncologist, contributing to the Stroke and Cerebrovascular Center and the Vascular Anomalies Center, and at Novo Nordisk and Forma Therapeutics as Executive Medical Director, leading clinical development for etavopivat in sickle cell disease and related conditions. Experience also includes a Director position at Novartis Institutes for BioMedical Research, providing expertise in hematology for first-in-human trials and pediatric studies. Education includes a MMSc from Harvard Medical School, an MD from the University of Tennessee-Health Science Center, and a BS in Biology from Tufts University.